bucindolol has been researched along with Blood Pressure, High in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comer, WT; Deitchman, D; Dennis, RD; Kreighbaum, WE; Matier, WL; Minielli, JL; Perhach, JL | 1 |
| Aban, IB; Ahmed, A; Ahmed, MI; de Denus, S; Desai, RV; Feller, MA; Guichard, JL; Mujib, M; White, M | 1 |
| Ackerson, L; Avins, AL; Neuhaus, J; Pressman, A; Rudd, P | 1 |
| Deedwania, P; Fagerberg, B; Ghali, J; Goldstein, S; Gottlieb, S; Hjalmarson, A; Kjekshus, J; Waagstein, F; Wedel, H; Wikstrand, J | 1 |
| Akman, D; Ali, I; Brendorp, B; Bruun, NE; Køber, L; Møller, J; Ottesen, M; Torp-Pedersen, C | 1 |
| Fedder, IL; Ferguson, RK; Rocci, ML; Rotmensch, HH; Soyka, L; Swanson, BN; Vlasses, PH | 1 |
| Deitchman, D; Snyder, RW | 1 |
| Oates, HF | 1 |
| Yancy, CW | 1 |
| Coull, A; Goodman, C; Rosendorff, C | 1 |
| Curzio, J; Reid, JL; Vincent, J | 1 |
| Jamieson, M; Petrie, JC; Robb, OJ; Verschueren, J; Webster, J | 1 |
| Lehtonen, A; Tanskanen, A; Temmerman, J | 1 |
| Deitchman, D; DeQuattro, V; Edmiston, WA; Foti, A; Kimura, S; Loo, R; Rigonan, K; Thien, S | 1 |
| Clementi, RA; Conner, DP; Deitchman, D; Ferguson, RK; Oren, A; Vlasses, PH | 1 |
| Lefflerová, K; Widimský, J | 1 |
| Kelman, AW; McSharry, DR; Meredith, PA; Reid, JL; Vincent, J | 1 |
2 review(s) available for bucindolol and Blood Pressure, High
| Article | Year |
|---|---|
The role of race in heart failure therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Incidence; Prognosis; Propanolamines; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Ventricular Dysfunction, Left | 2002 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
6 trial(s) available for bucindolol and Blood Pressure, High
| Article | Year |
|---|---|
Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Blood Pressure Determination; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Propanolamines; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Sex Factors; Stroke Volume; Survival Rate; Treatment Outcome | 2012 |
Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST).
Topics: Adrenergic beta-Antagonists; Confidence Intervals; Double-Blind Method; Female; Humans; Hypertension; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Placebo Effect; Placebos; Propanolamines; Treatment Outcome; United States | 2012 |
Importance of a history of hypertension for the prognosis after acute myocardial infarction--for the Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) study group.
Topics: Adult; Aged; Aged, 80 and over; Denmark; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Propanolamines; Registries; Retrospective Studies; Risk Factors; Survival Rate; Vasodilator Agents | 2004 |
Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propanolamines; Renin; Vasodilator Agents | 1984 |
A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Posture; Propanolamines; Time Factors | 1985 |
Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Physical Exertion; Propanolamines; Random Allocation; Regional Blood Flow; Vascular Resistance | 1987 |
9 other study(ies) available for bucindolol and Blood Pressure, High
| Article | Year |
|---|---|
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanolamines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1980 |
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Topics: Adrenergic beta-Antagonists; Black People; Diabetic Angiopathies; Heart Failure; Humans; Hypertension; Meta-Analysis as Topic; Metoprolol; Multicenter Studies as Topic; Myocardial Infarction; Practice Patterns, Physicians'; Propanolamines; Randomized Controlled Trials as Topic | 2003 |
Beneficial effects of bucindolol in a canine model of pentobarbital-induced heart failure.
Topics: Animals; Blood Pressure; Dogs; Female; Heart Failure; Heart Rate; Hypertension; Indoles; Male; Pentobarbital; Propanolamines; Vascular Resistance | 1981 |
New antihypertensive agent (bucindolol)
Topics: Animals; Antihypertensive Agents; Hypertension; Indoles; Propanolamines; Rats | 1980 |
Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Propanolamines; Time Factors | 1985 |
Bucindolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Creatine Kinase; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Norepinephrine; Phenylephrine; Posture; Propanolamines; Receptors, Adrenergic, alpha; Renin | 1985 |
Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Propanolamines; Triglycerides | 1987 |
Efficacy of bucindolol in systemic hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Electrocardiography; Exercise Test; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propanolamines | 1987 |
The pharmacokinetics of bucindolol and its major metabolite in essential hypertension.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Propanolamines | 1985 |